评估草药-药物相互作用潜力的硅引导方法:三尖杉叶提取物案例研究。

IF 2.1 4区 医学 Q3 CHEMISTRY, MEDICINAL
Planta medica Pub Date : 2024-09-01 Epub Date: 2024-07-09 DOI:10.1055/a-2363-5033
Jeong In Seo, Young Beom Kwak, Seong Eun Cho, Hye Hyun Yoo
{"title":"评估草药-药物相互作用潜力的硅引导方法:三尖杉叶提取物案例研究。","authors":"Jeong In Seo, Young Beom Kwak, Seong Eun Cho, Hye Hyun Yoo","doi":"10.1055/a-2363-5033","DOIUrl":null,"url":null,"abstract":"<p><p><i>Cudrania tricuspidata</i> leaf extracts have long been utilized as traditional oriental medicines across Asian countries like Korea, China, and Japan. These extracts are renowned for their therapeutic benefits in addressing inflammation, tumors, obesity, and diabetes, maintaining their status as a pivotal folk remedy. Given the rising trend of combining medicinal herbs with conventional medications, it is imperative to explore the potential herb-drug interactions. However, there is a dearth of research on evaluating the herb-drug interactions of <i>C. tricuspidata</i> leaf extracts. Also, the intricate chemical composition of medicinal herbs presents methodological hurdles in establishing causal relationships between their constituents and herb-drug interactions. To overcome these challenges, a combined <i>in silico</i> and <i>in vitro</i> workflow was developed and effectively applied to evaluate the potential herb-drug interaction of <i>C. tricuspidata</i> leaf extracts along with the associated chemical factors. In <i>in vitro</i> CYP inhibition assays, <i>C. tricuspidata</i> leaf extracts exhibited potent inhibition of CYP1A2 and CYP2C8, with quercetin, kaempferol, and their glycosides identified as the major constituents. <i>In silico</i> analysis based on the prediction tools (ADMETlab 2.0 and pkCSM) identified key contributors to CYP inhibition, quercetin and kaempferol. Additionally, molecular docking analysis validated the binding of ligands (quercetin and kaempferol) to proteins (CYP1A2 and CYP2C8). These findings suggest that <i>C. tricuspidata</i> leaf extracts could inhibit CYP1A2 and CYP2C8, aiding in understanding the herb-drug interaction potential of <i>C. tricuspidata</i> leaf extracts for safe clinical application. Furthermore, this approach can be broadly applied to study herb-drug interactions of various medicinal herbs, enhancing their therapeutic benefits and reducing adverse reactions by considering chemical profiles relevant to herb-drug interaction potential in herbal preparations.</p>","PeriodicalId":20127,"journal":{"name":"Planta medica","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An In Silico-Guided Approach for Assessing Herb-Drug Interaction Potential: A Case Study with Cudrania tricuspidata Leaf Extracts.\",\"authors\":\"Jeong In Seo, Young Beom Kwak, Seong Eun Cho, Hye Hyun Yoo\",\"doi\":\"10.1055/a-2363-5033\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><i>Cudrania tricuspidata</i> leaf extracts have long been utilized as traditional oriental medicines across Asian countries like Korea, China, and Japan. These extracts are renowned for their therapeutic benefits in addressing inflammation, tumors, obesity, and diabetes, maintaining their status as a pivotal folk remedy. Given the rising trend of combining medicinal herbs with conventional medications, it is imperative to explore the potential herb-drug interactions. However, there is a dearth of research on evaluating the herb-drug interactions of <i>C. tricuspidata</i> leaf extracts. Also, the intricate chemical composition of medicinal herbs presents methodological hurdles in establishing causal relationships between their constituents and herb-drug interactions. To overcome these challenges, a combined <i>in silico</i> and <i>in vitro</i> workflow was developed and effectively applied to evaluate the potential herb-drug interaction of <i>C. tricuspidata</i> leaf extracts along with the associated chemical factors. In <i>in vitro</i> CYP inhibition assays, <i>C. tricuspidata</i> leaf extracts exhibited potent inhibition of CYP1A2 and CYP2C8, with quercetin, kaempferol, and their glycosides identified as the major constituents. <i>In silico</i> analysis based on the prediction tools (ADMETlab 2.0 and pkCSM) identified key contributors to CYP inhibition, quercetin and kaempferol. Additionally, molecular docking analysis validated the binding of ligands (quercetin and kaempferol) to proteins (CYP1A2 and CYP2C8). These findings suggest that <i>C. tricuspidata</i> leaf extracts could inhibit CYP1A2 and CYP2C8, aiding in understanding the herb-drug interaction potential of <i>C. tricuspidata</i> leaf extracts for safe clinical application. Furthermore, this approach can be broadly applied to study herb-drug interactions of various medicinal herbs, enhancing their therapeutic benefits and reducing adverse reactions by considering chemical profiles relevant to herb-drug interaction potential in herbal preparations.</p>\",\"PeriodicalId\":20127,\"journal\":{\"name\":\"Planta medica\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Planta medica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2363-5033\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/9 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Planta medica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2363-5033","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/9 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

在韩国、中国和日本等亚洲国家,三尖杉叶提取物(CLEs)一直被用作传统的东方药物。这些提取物因其在治疗炎症、肿瘤、肥胖症和糖尿病方面的疗效而闻名,并一直保持着重要的民间疗法的地位。鉴于药用草药与传统药物相结合的趋势日益明显,探索潜在的草药-药物相互作用(HDIs)势在必行。然而,有关评估 CLEs HDIs 的研究却十分匮乏。此外,药材的化学成分错综复杂,在确定其成分与 HDIs 之间的因果关系方面存在方法上的障碍。为了克服这些挑战,我们开发了一套硅学和体外相结合的工作流程,并将其有效地应用于评估 CLEs 潜在的 HDI 以及相关的化学因素。在体外 CYP 抑制试验中,CLEs 表现出对 CYP1A2 和 CYP2C8 的强效抑制作用,其中槲皮素、山奈酚及其苷类被确定为主要成分。基于预测工具(ADMETlab2.0 和 pkCSM)的硅学分析确定了槲皮素和山奈酚这两种抑制 CYP 的主要成分。此外,分子对接(MD)分析验证了配体(槲皮素和山柰醇)与蛋白质(CYP1A2 和 CYP2C8)的结合。这些研究结果表明,CLEs 可抑制 CYP1A2 和 CYP2C8,有助于了解 CLEs 在安全临床应用方面的 HDI 潜力。此外,这种方法可广泛应用于研究各种药材的 HDI,通过考虑药材制剂中与 HDI 潜力相关的化学特征,提高其治疗效果并减少不良反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
An In Silico-Guided Approach for Assessing Herb-Drug Interaction Potential: A Case Study with Cudrania tricuspidata Leaf Extracts.

Cudrania tricuspidata leaf extracts have long been utilized as traditional oriental medicines across Asian countries like Korea, China, and Japan. These extracts are renowned for their therapeutic benefits in addressing inflammation, tumors, obesity, and diabetes, maintaining their status as a pivotal folk remedy. Given the rising trend of combining medicinal herbs with conventional medications, it is imperative to explore the potential herb-drug interactions. However, there is a dearth of research on evaluating the herb-drug interactions of C. tricuspidata leaf extracts. Also, the intricate chemical composition of medicinal herbs presents methodological hurdles in establishing causal relationships between their constituents and herb-drug interactions. To overcome these challenges, a combined in silico and in vitro workflow was developed and effectively applied to evaluate the potential herb-drug interaction of C. tricuspidata leaf extracts along with the associated chemical factors. In in vitro CYP inhibition assays, C. tricuspidata leaf extracts exhibited potent inhibition of CYP1A2 and CYP2C8, with quercetin, kaempferol, and their glycosides identified as the major constituents. In silico analysis based on the prediction tools (ADMETlab 2.0 and pkCSM) identified key contributors to CYP inhibition, quercetin and kaempferol. Additionally, molecular docking analysis validated the binding of ligands (quercetin and kaempferol) to proteins (CYP1A2 and CYP2C8). These findings suggest that C. tricuspidata leaf extracts could inhibit CYP1A2 and CYP2C8, aiding in understanding the herb-drug interaction potential of C. tricuspidata leaf extracts for safe clinical application. Furthermore, this approach can be broadly applied to study herb-drug interactions of various medicinal herbs, enhancing their therapeutic benefits and reducing adverse reactions by considering chemical profiles relevant to herb-drug interaction potential in herbal preparations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Planta medica
Planta medica 医学-药学
CiteScore
5.10
自引率
3.70%
发文量
101
审稿时长
1.8 months
期刊介绍: Planta Medica is one of the leading international journals in the field of natural products – including marine organisms, fungi as well as micro-organisms – and medicinal plants. Planta Medica accepts original research papers, reviews, minireviews and perspectives from researchers worldwide. The journal publishes 18 issues per year. The following areas of medicinal plants and natural product research are covered: -Biological and Pharmacological Activities -Natural Product Chemistry & Analytical Studies -Pharmacokinetic Investigations -Formulation and Delivery Systems of Natural Products. The journal explicitly encourages the submission of chemically characterized extracts.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信